ClinicalTrials.gg
Not yet recruitingNCT07921134Updated Nov 6, 2026

Effects of Clinic Versus mHealth Application-Based Shoulder Rehabilitation in Patients With Adhesive Capsulitis

An interventional study of Clinic-Based Shoulder Rehabilitation (Therapist-supervised Exercises + MWM) and mHealth Application-Based Shoulder Rehabilitation (App-guided Exercises + self-administered MWM) in Adhesive Capsulitis, sponsored by Riphah International University. Not yet recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
86
Allocation
Non-randomized
Ages
40 Years to 65 Years
Sex
All
01

Study summary

This quasi-experimental study aims to compare clinic-based versus mHealth application-based shoulder rehabilitation in patients with adhesive capsulitis, focusing on shoulder range of motion, functional disability, pain intensity, and exercise adherence.

Read the detailed description

Adhesive capsulitis (AC), or frozen shoulder, is an insidious inflammatory disorder characterized by a painful, progressive decrease in passive or active glenohumeral joint range of motion caused by gradual fibrosis and subsequent contracture of the glenoid capsule. The condition progresses through freezing, frozen and thawing phases. In the frozen stage, pain gradually decreases and is usually experienced at the ends of the range of motion, with characteristic progressive loss of glenohumeral external rotation, abduction, internal rotation and flexion. Physiotherapy management may include moist heat, strengthening, stretching, mobilization techniques, MWM, pendulum exercises, wall ladder exercises and capsular stretching.

Clinic-based rehabilitation provides supervised mobilization and exercise, whereas mHealth-based rehabilitation can provide structured and accessible exercise programs remotely. The synopsis identifies a research gap in directly comparing these delivery models, particularly with regard to range of motion, functional disability, pain and exercise adherence. In this study, the clinic-based group will receive therapist-supervised joint mobilization and therapeutic exercises, while the mHealth application-based group will perform an identical structured exercise program through PhysiApp, with exercises prescribed using Physitrack. The app-based group will also perform self-administered MWM using theraband with video instructions.

02

Conditions studied

  • Adhesive Capsulitis

Browse trials for

Keywords

  • Frozen Shoulder
  • Clinic-Based Rehabilitation,
  • Mobilization with Movement (MWM)
03

In context

Bursitis

383 studies on the registry are indexed under Bursitis; 111 are open to participants now.

This study's planned enrollment of 86 is above the median of 44 across 346 interventional studies indexed under Bursitis.

Browse Bursitis studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,193 studies on the registry; 650 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with unilateral frozen shoulder.
  • Patients with stage 2 adhesive capsulitis (frozen stage).
  • Loss of ≥50% of shoulder ROM in both active and passive range, symmetrical in all directions, with symptoms persisting for at least 4 months.
  • Patients will be allocated based on feasibility: individuals unable to attend regular clinic sessions but having access to a smartphone will be assigned to the app-based rehabilitation group, while those able to attend regular clinic sessions will be assigned to the supervised rehabilitation group.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic illnesses such as diabetes mellitus or rheumatoid arthritis.
  • Patients with shoulder pathologies including rotator cuff tears, ligament injuries, or in the shoulder region.
  • Patients with neurological disorders affecting the upper limb.
  • Patients with a history of previous surgery or manipulation under anesthesia of the affected shoulder.
  • Secondary adhesive capsulitis caused by trauma such as shoulder fracture or dislocation.
  • Local injection to the affected shoulder within the last three months or current corticosteroid therapy.

Pregnancy.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
86 participants (estimated)

Study arms

  • Experimental
    Clinic-Based Shoulder Rehabilitation (Therapist-supervised Exercises + MWM)

    Hot pack: 15 minutes prior to session. Pendulum/Codman and wall ladder exercises (10 reps × 3 sets). Capsular stretching: anterior, posterior and inferior shoulder stretch (hold for 20 seconds × 5 repetitions). MWM: Flexion-posterior glide with Mulligan belt; external rotation-posterolateral glide; abduction-inferior glide; internal rotation-inferior glide, with active movement within pain-free range. Dosage: 2 sets × 10 reps each with 1 min rest between each set. Home exercises: twice daily

    Other: Clinic-Based Shoulder Rehabilitation (Therapist-supervised Exercises + MWM)

  • Other
    mHealth Application-Based Shoulder Rehabilitation (App-guided Exercises + self-administered MWM)

    Hot pack: 15 minutes prior to session. Pendulum/Codman and wall ladder exercises (10 reps × 3 sets). Capsular stretching: anterior, posterior and inferior shoulder stretch (hold for 20 seconds × 5 repetitions). MWM via app guidance: Flexion-posterior glide with theraband; external rotation-posterolateral glide; abduction-inferior glide; internal rotation-inferior glide, with active movement within pain-free range. Dosage: 2 sets × 10 reps each with 1 min rest between each set. Exercises performed using app-based video instructions. Home exercises: twice daily

    Other: mHealth Application-Based Shoulder Rehabilitation (App-guided Exercises + self-administered MWM)

Interventions

  • OtherClinic-Based Shoulder Rehabilitation (Therapist-supervised Exercises + MWM)

    1- Hot pack: 15 minutes prior to session. 2- Pendulum/Codman and wall ladder exercises (10 reps × 3 sets). 3- Capsular stretching: anterior, posterior and inferior shoulder stretch (hold for 20 seconds × 5 repetitions). 4- MWM: Flexion-posterior glide with Mulligan belt; external rotation-posterolateral glide; abduction-inferior glide; internal rotation-inferior glide, with active movement within pain-free range. 5- Dosage: 2 sets × 10 reps each with 1 min rest between each set. 6- Home exercises: twice daily

  • OthermHealth Application-Based Shoulder Rehabilitation (App-guided Exercises + self-administered MWM)

    Hot pack: 15 minutes prior to session. 2- Pendulum/Codman and wall ladder exercises (10 reps × 3 sets). 3- Capsular stretching: anterior, posterior and inferior shoulder stretch (hold for 20 seconds × 5 repetitions). 4- MWM via app guidance: Flexion-posterior glide with theraband; external rotation-posterolateral glide; abduction-inferior glide; internal rotation-inferior glide, with active movement within pain-free range. 5- Dosage: 2 sets × 10 reps each with 1 min rest between each set. 6- Exercises performed using app-based video instructions. 7- Home exercises: twice daily

06

What researchers measure

Primary outcomes

  1. Goniometer

    A standard instrument used in clinical settings to quantify joint range of motion in degrees by aligning its arms with designated bony landmarks. Standard goniometer reliability: ICC = 0.749-0.949.

    Time frame: 4 weeks

  2. Shoulder Pain and Disability Index (SPADI)

    A patient-reported outcome measure comprising 13 items across pain and disability subscales. Scores range from 0 (best) to 100 (worst). It has high test-retest reliability with ICC = 0.989 for pain and ICC = 0.990 for disability.

    Time frame: 4 weeks

  3. Exercise Adherence Rating Scale (EARS)

    A self-report questionnaire containing six items rated on a five-point Likert scale, with a minimum value of 0 and maximum value of 24. Higher values indicate greater consistency. Test-retest reliability is: ICC = 0.97.

    Time frame: 4 weeks

  4. Numeric Pain Rating Scale (NPRS)

    A scale assessing pain severity from 0 to 10, where 0 represents no pain and 10 represents the worst pain that can be felt by the patient. Reliability: ICC = 0.67.

    Time frame: 4 weeks

07

Study locations

1 site
  • Orthoflex Physiotherapy & Rehabilitation Clinic
    Islamabad, Punjab Province, Pakistan
    • Maria Khalid, MSOMPT · Contactmaria.khalid@riphah.edu.pk · 03315369768
    • Sumaira Muslim, MSOMPT* · Contact
    • Sumaira Muslim, MSOMPT* · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07921134
Responsible party
Sponsor
First posted
Nov 6, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jul 2027 (estimated)
Completion
Jul 2027 (estimated)
Last update
Nov 6, 2026

Study contacts

Maria Khalid, MSOMPT
Contact
maria.khalid@riphah.edu.pk
03315369768
Maria Khalid
principal investigator · Riphah International University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion